TestAVec researchers have identified contaminating sequences within HIV-1 viruses used for gene therapy. Researchers from Brunel...

The first patient dosed with in vivo CAR-T gene therapy has now taken place. Interius BioTherapeutics have announced the first use of in...

Further incidences of insertional mutagenesis related cancer have been identified in patients treated for cerebral adrenoleukodystrophy...

TestAVec's chairman, Mr Robert Spencer, and Chief Scientific Officer, Prof. Micahel Themis, will be attending this year's congress of the...

In March 2023, the NC3Rs and UKEMS hosted a groundbreaking meeting, originally conceived by TestAVec and Novartis, of top experts in gene...